PME3 tox Flashcards
What are the steps in the Primary Survey for general management approach?
Scene safety: assess and ensure no ongoing harm. Airway: anticipate airway loss, suction as necessary. Breathing: support ventilations if necessary. Circulation: assess for dysrhythmias, shock, and adequacy of circulation. Disability: consider 4 Hs & 4 Ts. Exposure: decontamination and isolate emesis.
What should be included in the Secondary Survey for general management approach?
Detailed history taking, including medications, allergies, and past medical history. Physical examination tailored to the clinical presentation.
What does the Reassessment involve in the general management approach?
Continuous monitoring of patient’s response to interventions. Reevaluate and adjust management plans based on patient’s progress and any deterioration.
What are the clinical features of Anticholinergic Toxidrome?
Agitated delirium, tachycardia, hyperthermia, dilated pupils, dry flushed skin, urinary retention.
What are the common causes of Anticholinergic Toxidrome?
Antipsychotics, antihistamines, tricyclic antidepressants, benztropine, atropine, carbamazepine.
What is the management for Anticholinergic Toxidrome?
Physostigmine as an antidote. Supportive care, including cooling measures for hyperthermia and sedation if necessary.
What are the clinical features of Opiate Toxidrome?
Decreased conscious state, bradypnoea/apnoea, miosis, ventilatory failure.
What are the common causes of Opiate Toxidrome?
Heroin, morphine, other opiates.
What is the management for Opiate Toxidrome?
Naloxone administration. Ventilatory support and monitoring of respiratory function.
What are the clinical features of Mixed Cholinergic Toxidrome?
Brady- or tachycardia, hypo- or hypertension, miosis or mydriasis, sweating, salivation, bronchospasm, muscle weakness.
What are the common causes of Mixed Cholinergic Toxidrome?
Organophosphates, carbamates, chemical warfare agents.
What is the management for Mixed Cholinergic Toxidrome?
Atropine and oximes as antidotes. Supportive care including ventilatory support.
What are the clinical features of Sympathomimetic Toxidrome?
Hypertension, tachycardia, agitation, mydriasis, sweating.
What are the common causes of Sympathomimetic Toxidrome?
Amphetamines, cocaine.
What is the management for Sympathomimetic Toxidrome?
Beta blockers (e.g., propranolol) for specific conditions. Supportive care focusing on cardiovascular and neurological stability.
What are the clinical features of Serotonin Syndrome?
Altered mental state, autonomic dysfunction, hyperthermia, sweating, hyperreflexia, clonus/myoclonus.
What is the management for Serotonin Syndrome?
Supportive care, including cooling for hyperthermia. Benzodiazepines for seizures and agitation.
What should be monitored in Serotonin Syndrome?
Monitoring for and managing complications like hyperkalaemia.
What are the clinical features of Tricyclic Antidepressant (TCA) Overdose?
Rapid CNS deterioration, seizures, QRS prolongation, terminal R wave in aVR.
What is the management for Tricyclic Antidepressant (TCA) Overdose?
Sodium bicarbonate for sodium channel blockade. Amiodarone for refractory ventricular tachycardia or fibrillation.
What should be monitored in Tricyclic Antidepressant (TCA) Overdose?
Early airway management and supportive care.
What are the clinical features of Monoamine Oxidase Inhibitor (MAOI) Overdose?
Agitation, confusion, seizures, hyperthermia, sympathomimetic toxicity.